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Introduction
Menthol (2-isopropyl-5-methyl-cyclohexanol) is widely appreciated for its ability to produce a cooling sensation. It is used as a constituent of food, drink, tobacco and cosmetics in the daily life. It can reduce flatulence and colic pain in patients with irritable bowel syndrome [1] . It was shown to reduce dyspnea in many respiratory conditions [2] . It is recognized as a naturally-occurring cold receptor agonist that specifically activates the transient receptor potential melastatin 8 (TRPM8) channel in the skin and mucous membranes [3] . It can induce a cooling sensation that appears to reduce the perception of respiratory effort without actually altering the temperature of the skin or mucous membranes [4] [5] [6] . Because of the possible dual action of menthol on sensory nerves and smooth muscle, it may have a therapeutic role in upper respiratory tract infection, bronchitis and asthma. These properties of menthol point towards a
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International Publisher compound of dual efficacy which may be an effective and well tolerated treatment for both respiratory tract infection and asthma by improving airways caliber and alleviating the associated cough.
To date, the effect of menthol on tracheal smooth muscle has been rarely explored. It has been used as a nasal inhalation solution in the daily life. Therefore, during administration of the menthol for nasal symptoms, it might also affect the trachea via oral intake or inhalation. Menthol, however, is a selective cold receptor agonist and offers an opportunity to examine the role of cold receptors in isolation. Since asthma is one of those allergic diseases, it is reasonable to explore the role of menthol in tracheal smooth muscle. During an asthmatic attack, the tracheal smooth muscle plays an important role in reducing pulmonary function as it becomes contracted. The aim of this study was to determine the effects of menthol on isolated tracheal smooth muscle in vitro.
Materials and methods
Chemicals used were of the highest purity available. All the chemical reagents were obtained from Sigma (St. Louis, MO, USA). We tested methacholine as a tracheal contraction drug. Eighteen rats were anesthetized by intraperitoneal administration of pentobarbital (45 mg/kg) and two pieces of trachea (about 5 mm in length) were removed from each rat. This study was approved by an animal experiment review board (LAC-2013-0098).
The tracheal specimen was mounted using two steel plates and submersed in a 30ml muscle bath at 37°C as the previous report [7, 8] . The bath (Fig. 1 Our preliminary studies showed that the vehicle (diluted DMSO) had no effect on the in vitro studies of rat tracheal smooth muscle. The upper side of the tracheal strip was attached to a Grass FT-03 force displacement transducer (AstroMed, West Warwick, RI, USA) using a steel plate and a 3-0 silk ligature. The other side of the strip was fixed to a steel plate attached to the bath. A passive tension of 0.3 g was applied to the strips and subsequent changes in tension were recorded continuously using Chart V4.2 software (PowerLab, ADInstruments, Colorado Springs, CO, USA). Preliminary tests showed that the tracheal strip immersed in the bath solution used for subsequent experiments did not contract when basal tension was applied. Before drug assays were conducted, isolated tracheas were equilibrated in the bath solution for 15-30 min, during which continuous aeration with a mixture of 95% O2 and 5% CO 2 was applied. Stepwise increases in the amount of drugs used were employed to study contraction or relaxation responses of tracheal strips. All drugs were administered by adding a defined volume of stock solution to the tissue bath solution. In each experiment, one untreated strip served as a control. Electrical field stimulation (EFS) (5 Hz, 5 ms pulse duration, at a voltage of 50 V, trains of stimulation for 5 seconds) was applied to the trachea strip with two wire electrodes placed parallel to the trachea strip and connected to a direct-current stimulator (Grass S44, Quincy, MA, USA). An interval of 2 minutes was imposed between each stimulation period to allow recovery from the response. Stimulation was applied contiguously to the trachea at 37°C.
The following assessments for menthol were performed: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 10 -6 M methacholine; (3) effect of menthol on electrically induced tracheal smooth muscle contractions.
The concentrations of drugs were expressed as concentrations present in the 30ml bath solution. Data were presented as mean values and standard deviations (SDs). Differences between mean values were compared using Student's t-test. Differences were assumed to be significant at P < 0.05.
Results
The degree of contraction or relaxation of tracheal strips was estimated from the tension applied to the transducer. Tracheal contraction induced by a small dose of methacholine was easily detected (not shown), and the tissue remained in a contracted state until the drug was rinsed from the tissue.
Addition of the cold receptor agonist, menthol, on the basal tension elicited a negligible response (Fig.  2) , but resulted in a small relaxation of the trachea when introduced after the addition of a constricting agent such as 10 -6 M methacholine (Fig. 3, 4) . Low doses of menthol resulted in a mild effect on contraction and higher doses slightly relaxed the trachea smooth muscle (Fig. 4) . At 10 -8 M menthol, the tension was 99.5% of control values (Fig. 4) . While at 10 -5 M and 10 -4 M menthol, the tensions were 80.1% and 71.0%, respectively (Fig. 4) . The difference of tension among 10 -8 M menthol and 10 -5 M or 10 -4 M menthol was statically significant (P<0.05).
Menthol also inhibited the spike contraction induced by EFS (Fig. 5, 6 ). The peak tension of the tracheal strip evoked by EFS upon the addition of 10 -8 M menthol was 97.4%, while at 10 -5 M and 10 -4 M menthol they were 44.6% and 20.7%, respectively ( 
Discussion
Although tracheal responses to drugs by in vitro assays have been developed by other groups [9, 10] , our method provides distinct advantages [7] . Our test only requires a few millimeters of trachea, which is excised as an intact ring. An intact tracheal ring is an important component of our technique [7] , and is in contrast to previous authors' use of tracheal smooth muscle strips to conduct drug tests [9] [10] [11] . Our test is simpler and more robust than the tests in which tracheal rings are destroyed. Furthermore, an intact tracheal ring is much more representative of a physiological setting than smooth muscle strips.
Nevertheless, the results of our experiments should be interpreted within the context of the test materials used. Although it was difficult to determine which tissue component of the trachea was responsible for drug-induced contraction, the nature of specific tissues and their responses to specific drugs provided some indication. Firstly, the tracheal strips used in our study were crude preparations that contained cartilage and tracheal smooth muscle. The smooth muscle of the trachea appeared to be the main tissue component responsible for contraction, as the other components (epithelium, glands, connective tissue, nerves, and cartilage) did not contract to a significant extent. Because this method involved cross contraction, changes in tension were caused by radial contraction of the tracheal ring. Although responses to drugs and electrical stimulation have been verified for similar preparations [9] [10] [11] , the contractile response observed in this study was probably an aggregate of the responses of various types of muscle tissue. Secondly, the isolated tracheal preparations used in our experiments were excised from rats without damaging the endothelium or smooth muscle. Therefore, it is reasonable to assume that tracheal responses to test agents in our study are comparable to those observed after application of a spray or drug inhalation to the trachea during an asthma attack.
The cholinergic contracting agent tested in this preparation is commonly used for research purposes. It is noteworthy that menthol-induced relaxation of tissue was dependent on prior partial contraction of smooth muscle using methacholine. Thus, it should thus be possible to assay the effects of common drugs and potential therapeutic agents supposedly responsible for relieving asthma. Menthol, a cold receptor agonist, could mildly reduce methacholine-induced contraction. It is known as a TMRP8 agonist [12] , yet the mechanism by which this cold receptor agonist affected the trachea smooth muscle is unknown and further studies are needed to elucidate this question.
Electrical field stimulation is a common experimental tool and it activates the nerve terminals within the tissue to be tested and induces the release of endogenous neurotransmitters thereby triggering the smooth muscle to contract. EFS-induced spike contraction of canine nasal mucosa, which is believed to result from the contraction of vascular smooth muscles, disappeared after ipsilateral cervical sympathetic ganglionectomy [13] . Thus, EFS-induced spike contraction of isolated canine nasal mucosa was proved to be meditated by sympathetic innervation [13] . In this study, EFS-induced spike contraction of the tracheal smooth muscle was believed to be from the stimulation of parasympathetic innervation. Therefore, EFS-induced contraction of the trachea was decreased as the menthol concentration was increased. These findings suggest that a TMRP8 agonist could antagonize the parasympathetic innervation responsible for trachea smooth muscle contraction. Menthol non-selectively inhibits both Ca2+ influx pathways, voltage-dependent Ca2+ channels and receptor-operated Ca2+ entry in guinea pig tracheal smooth muscle [14, 15] . Clearly, what was observed in this study is very interesting, but further study is needed to clarify these phenomena.
Menthol inhibited contractions induced by EFS. In general, Ca2+ influx plays an important role in determining the contractile force of smooth muscle by activating myosin light-chain kinase (MLCK) and subsequent phosphorylation of the myosin light chain [16] . Methacholine are known to activate different Ca2+ influx pathways, i.e., receptor-operated Ca2+ entry and voltage-dependent Ca2+channels (mostly dihydropyridine-sensitive L-type Ca2+ channels), respectively [17] . The inhibitory effects of menthol on Ca2+ influx and contraction were similar to those of non-selective inhibitors of Ca2+ channels such as SKF-96365, as reported previously [18, 19] . Thus, the present results indicate that menthol attenuated both contractions induced by methacholine and EFS in rat tracheal smooth muscle. Menthol has been recognized as a compound that activates the cold receptors in sensory neurons [5] . Involvement of the cold receptors sensitive to menthol has also been proposed in nonneuronal cells [5, 16] . Taken together, these findings indicate that stimulation of an unknown cold receptor may be involved in the relaxation mediated by menthol in guinea pig tracheal smooth muscle.
The present study demonstrated that cold receptor did exist in the trachea. Some authors have demonstrated that nasal menthol inhalation is associated with a subjective sensation of improved airflow, but without any objective change in nasal resistance [20, 21] . The current study extends those findings by demonstrating that menthol is not associated with any significant change in basal tension.
These properties of menthol point towards a compound of dual efficacy which may be an effective and well tolerated treatment for both respiratory tract infection and mild asthma by improving airways caliber and alleviating the associated cough.
